Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of a cellular component.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of cellular component movement"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.996 | Fly | |
FN1 | fibronectin 1 | 0.995 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.986 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.985 | ||
FLNA | filamin A, alpha | 0.963 | ||
CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.950 | ||
TEK | TEK tyrosine kinase, endothelial | 0.948 | ||
JAG1 | jagged 1 | 0.944 | Human | |
THBS1 | thrombospondin 1 | 0.919 | ||
NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.877 | Human | |
C1QA | complement component 1, q subcomponent, A chain | 0.877 | Human | |
NOTCH3 | notch 3 | 0.860 | Human | |
NOTCH1 | notch 1 | 0.852 | ||
MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.843 | ||
TGFB1 | transforming growth factor, beta 1 | 0.838 | ||
RARA | retinoic acid receptor, alpha | 0.828 | ||
HOXB5 | homeobox B5 | 0.826 | Human | |
KRT15 | keratin 15 | 0.813 | Human | |
FKBP1A | FK506 binding protein 1A, 12kDa | 0.763 | ||
IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.722 | Human | |
VCAM1 | vascular cell adhesion molecule 1 | 0.719 | ||
BMP2 | bone morphogenetic protein 2 | 0.641 | ||
IFITM1 | interferon induced transmembrane protein 1 (9-27) | 0.638 | ||
SMN1 | survival of motor neuron 1, telomeric | 0.624 | ||
BAIAP2 | BAI1-associated protein 2 | 0.624 | ||
TBX5 | T-box 5 | 0.605 | ||
KRT6B | keratin 6B | 0.598 | ||
ANGPTL2 | angiopoietin-like 2 | 0.590 | Human | |
BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.590 | Human | |
TGFB3 | transforming growth factor, beta 3 | 0.584 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.578 | ||
IL1R1 | interleukin 1 receptor, type I | 0.572 | ||
TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.568 | ||
CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.568 | ||
CCR5 | chemokine (C-C motif) receptor 5 | 0.567 | ||
TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.562 | Human | |
FGFR2 | fibroblast growth factor receptor 2 | 0.550 | ||
COL5A1 | collagen, type V, alpha 1 | 0.530 | ||
TSC22D1 | TSC22 domain family, member 1 | 0.527 | ||
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.511 | Human | |
PLAU | plasminogen activator, urokinase | 0.508 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.506 | ||
IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0.501 | Human | |
APOC1 | apolipoprotein C-I | 0.489 | ||
KRT8 | keratin 8 | 0.484 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.483 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.478 | ||
NCOR2 | nuclear receptor corepressor 2 | 0.475 | ||
ABI2 | abl-interactor 2 | 0.471 | ||
COL1A1 | collagen, type I, alpha 1 | 0.470 | ||
C1QC | complement component 1, q subcomponent, C chain | 0.462 | Human | |
IGFBP4 | insulin-like growth factor binding protein 4 | 0.459 | Human | |
FGA | fibrinogen alpha chain | 0.458 | ||
SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.456 | ||
ADORA2A | adenosine A2a receptor | 0.453 | ||
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.447 | ||
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.444 | ||
SMAD3 | SMAD family member 3 | 0.423 | ||
ADRB1 | adrenergic, beta-1-, receptor | 0.419 | ||
CCL5 | chemokine (C-C motif) ligand 5 | 0.415 | Human | |
PAX8 | paired box 8 | 0.406 | ||
ACTN1 | actinin, alpha 1 | 0.394 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.393 | ||
MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.391 | ||
PXN | paxillin | 0.390 | ||
ESRRG | estrogen-related receptor gamma | 0.384 | ||
IL1B | interleukin 1, beta | 0.372 | ||
INHBA | inhibin, beta A | 0.343 | ||
EP300 | E1A binding protein p300 | 0.340 | ||
KCNA5 | potassium voltage-gated channel, shaker-related subfamily, member 5 | 0.336 | ||
BMPR1B | bone morphogenetic protein receptor, type IB | 0.333 | Human | |
SPTAN1 | spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) | 0.331 | ||
PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.330 | ||
ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.329 | ||
HOXA10 | homeobox A10 | 0.323 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.313 | Human | |
SEMA4A | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A | 0.310 | ||
EFNA5 | ephrin-A5 | 0.309 | ||
EFNA1 | ephrin-A1 | 0.306 | ||
HTT | huntingtin | 0.306 | ||
COX17 | COX17 cytochrome c oxidase assembly homolog (S. cerevisiae) | 0.305 | ||
CHD3 | chromodomain helicase DNA binding protein 3 | 0.305 | ||
TBXA2R | thromboxane A2 receptor | 0.300 | Human | |
HOXB6 | homeobox B6 | 0.300 | Human | |
GDF5 | growth differentiation factor 5 | 0.298 | Human | |
A2M | alpha-2-macroglobulin | 0.298 | Human | |
CD63 | CD63 molecule | 0.297 | Rat | |
C1QB | complement component 1, q subcomponent, B chain | 0.295 | Human | |
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.295 | ||
PPARG | peroxisome proliferator-activated receptor gamma | 0.294 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.293 | ||
KRT6A | keratin 6A | 0.292 | ||
HIPK2 | homeodomain interacting protein kinase 2 | 0.290 | ||
SMAD6 | SMAD family member 6 | 0.280 | ||
DSP | desmoplakin | 0.279 | ||
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.278 | ||
PKP1 | plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) | 0.276 | ||
WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.275 | ||
IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.274 | ||
NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.272 | ||
COL2A1 | collagen, type II, alpha 1 | 0.268 | ||
ACVR1 | activin A receptor, type I | 0.268 | Human | |
CCND1 | cyclin D1 | 0.265 | ||
NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.265 | ||
COL6A1 | collagen, type VI, alpha 1 | 0.264 | ||
CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.264 | ||
PLEC | plectin | 0.262 | ||
NCOA1 | nuclear receptor coactivator 1 | 0.261 | ||
NRP2 | neuropilin 2 | 0.259 | ||
KLF4 | Kruppel-like factor 4 (gut) | 0.259 | ||
VEGFC | vascular endothelial growth factor C | 0.256 | ||
WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.254 | ||
IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.249 | ||
MEF2A | myocyte enhancer factor 2A | 0.249 | ||
BCL6 | B-cell CLL/lymphoma 6 | 0.246 | ||
DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.245 | ||
PLAT | plasminogen activator, tissue | 0.245 | ||
PTRF | polymerase I and transcript release factor | 0.239 | ||
STAB1 | stabilin 1 | 0.238 | ||
CD34 | CD34 molecule | 0.237 | ||
ANGPT2 | angiopoietin 2 | 0.234 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.228 | ||
XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.228 | ||
GATA4 | GATA binding protein 4 | 0.227 | Human | |
TFF1 | trefoil factor 1 | 0.225 | ||
TSC2 | tuberous sclerosis 2 | 0.221 | ||
RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.220 | ||
KRT18 | keratin 18 | 0.220 | Human | |
LAMA4 | laminin, alpha 4 | 0.218 | ||
KRT19 | keratin 19 | 0.217 | Human | |
DUSP1 | dual specificity phosphatase 1 | 0.217 | ||
MAPK1 | mitogen-activated protein kinase 1 | 0.216 | ||
COL6A2 | collagen, type VI, alpha 2 | 0.214 | ||
NRP1 | neuropilin 1 | 0.214 | Mouse Rat | |
CTBP1 | C-terminal binding protein 1 | 0.212 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.209 | ||
EGFL7 | EGF-like-domain, multiple 7 | 0.209 | Mouse | |
HDAC7 | histone deacetylase 7 | 0.207 | Human | |
S100B | S100 calcium binding protein B | 0.204 | ||
PDX1 | pancreatic and duodenal homeobox 1 | 0.204 | ||
FLNB | filamin B, beta | 0.203 | ||
PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) | 0.200 | Human | |
SNX33 | sorting nexin 33 | 0.200 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.199 | Worm | |
HP | haptoglobin | 0.199 | ||
ENG | endoglin | 0.198 | ||
MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.197 | ||
COL4A2 | collagen, type IV, alpha 2 | 0.190 | ||
FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | 0.189 | ||
NCOR1 | nuclear receptor corepressor 1 | 0.188 | ||
EPHB3 | EPH receptor B3 | 0.188 | Human | |
CHRD | chordin | 0.188 | ||
DCN | decorin | 0.187 | ||
LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.186 | ||
IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.185 | ||
VCL | vinculin | 0.185 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.185 | Human | |
COL1A2 | collagen, type I, alpha 2 | 0.184 | ||
PROX1 | prospero homeobox 1 | 0.184 | ||
NOTCH4 | notch 4 | 0.184 | Human | |
HOXA6 | homeobox A6 | 0.183 | Human | |
PFN1 | profilin 1 | 0.181 | Human | |
IGFBP3 | insulin-like growth factor binding protein 3 | 0.176 | ||
VCAN | versican | 0.175 | ||
ITGA6 | integrin, alpha 6 | 0.173 | ||
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.173 | ||
FBLN1 | fibulin 1 | 0.171 | ||
LTBP4 | latent transforming growth factor beta binding protein 4 | 0.169 | ||
COL13A1 | collagen, type XIII, alpha 1 | 0.168 | ||
FGF3 | fibroblast growth factor 3 | 0.168 | ||
SPG21 | spastic paraplegia 21 (autosomal recessive, Mast syndrome) | 0.165 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.163 | ||
MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.163 | ||
JAG2 | jagged 2 | 0.162 | Human | |
VIM | vimentin | 0.161 | ||
BMPR1A | bone morphogenetic protein receptor, type IA | 0.160 | Human | |
TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.160 | Mouse | |
TBX2 | T-box 2 | 0.160 | ||
EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.158 | ||
MEF2C | myocyte enhancer factor 2C | 0.157 | ||
BMP1 | bone morphogenetic protein 1 | 0.154 | ||
VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.153 | ||
MYO10 | myosin X | 0.153 | ||
UTRN | utrophin | 0.153 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.152 | ||
LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.152 | ||
VWF | von Willebrand factor | 0.151 | ||
RARG | retinoic acid receptor, gamma | 0.150 | ||
MYH9 | myosin, heavy chain 9, non-muscle | 0.149 | ||
LMNA | lamin A/C | 0.148 | ||
SOD3 | superoxide dismutase 3, extracellular | 0.147 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.145 | Human | |
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.145 | ||
TGFB2 | transforming growth factor, beta 2 | 0.145 | Human | |
FAT1 | FAT tumor suppressor homolog 1 (Drosophila) | 0.144 | ||
MARK3 | MAP/microtubule affinity-regulating kinase 3 | 0.144 | ||
EMP3 | epithelial membrane protein 3 | 0.143 | ||
ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.142 | ||
DLL1 | delta-like 1 (Drosophila) | 0.141 | Human | |
HOXB3 | homeobox B3 | 0.141 | ||
ECM1 | extracellular matrix protein 1 | 0.141 | ||
EFNB2 | ephrin-B2 | 0.141 | ||
FOXF1 | forkhead box F1 | 0.141 | ||
PPAP2B | phosphatidic acid phosphatase type 2B | 0.141 | ||
PTPRC | protein tyrosine phosphatase, receptor type, C | 0.140 | ||
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.139 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.138 | ||
CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.138 | ||
GATA2 | GATA binding protein 2 | 0.138 | Human | |
ZBTB16 | zinc finger and BTB domain containing 16 | 0.137 | ||
APOE | apolipoprotein E | 0.137 | ||
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.136 | ||
PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.135 | ||
TGFA | transforming growth factor, alpha | 0.135 | ||
SLIT3 | slit homolog 3 (Drosophila) | 0.135 | Human Worm | |
DYNC1I1 | dynein, cytoplasmic 1, intermediate chain 1 | 0.134 | ||
COL4A1 | collagen, type IV, alpha 1 | 0.134 | ||
MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.134 | ||
PTK2 | PTK2 protein tyrosine kinase 2 | 0.131 | Rat | |
ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | 0.130 | ||
TJP1 | tight junction protein 1 (zona occludens 1) | 0.130 | ||
AGRN | agrin | 0.130 | ||
KRT13 | keratin 13 | 0.130 | Human | |
PRKCE | protein kinase C, epsilon | 0.129 | ||
POU5F1 | POU class 5 homeobox 1 | 0.129 | ||
ADAM9 | ADAM metallopeptidase domain 9 | 0.129 | ||
ZYX | zyxin | 0.129 | ||
PLTP | phospholipid transfer protein | 0.127 | ||
SFN | stratifin | 0.126 | ||
FGF18 | fibroblast growth factor 18 | 0.126 | ||
TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.125 | Human | |
CCL19 | chemokine (C-C motif) ligand 19 | 0.125 | Human | |
DPP4 | dipeptidyl-peptidase 4 | 0.124 | ||
ITGB5 | integrin, beta 5 | 0.124 | Fly | |
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.124 | ||
PVRL3 | poliovirus receptor-related 3 | 0.123 | ||
ATF5 | activating transcription factor 5 | 0.123 | ||
MAPK7 | mitogen-activated protein kinase 7 | 0.122 | ||
HIC1 | hypermethylated in cancer 1 | 0.122 | ||
HOXA2 | homeobox A2 | 0.121 | ||
VEGFA | vascular endothelial growth factor A | 0.120 | ||
MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.119 | ||
DARC | Duffy blood group, chemokine receptor | 0.118 | ||
YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.118 | ||
LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.118 | ||
PTGDS | prostaglandin D2 synthase 21kDa (brain) | 0.118 | ||
CCND2 | cyclin D2 | 0.117 | ||
APP | amyloid beta (A4) precursor protein | 0.116 | ||
OSMR | oncostatin M receptor | 0.115 | ||
IL1R2 | interleukin 1 receptor, type II | 0.113 | ||
PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.112 | ||
ATN1 | atrophin 1 | 0.112 | ||
TSPAN4 | tetraspanin 4 | 0.111 | ||
THBS2 | thrombospondin 2 | 0.110 | Human | |
SLIT2 | slit homolog 2 (Drosophila) | 0.110 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.109 | ||
DUSP6 | dual specificity phosphatase 6 | 0.108 | ||
CD248 | CD248 molecule, endosialin | 0.108 | ||
TCF4 | transcription factor 4 | 0.108 | ||
CYTH4 | cytohesin 4 | 0.108 | ||
EFNB1 | ephrin-B1 | 0.108 | ||
WNT2 | wingless-type MMTV integration site family member 2 | 0.108 | Human | |
SFRP2 | secreted frizzled-related protein 2 | 0.107 | Human Mouse | |
PTN | pleiotrophin | 0.107 | ||
PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.107 | ||
FLT4 | fms-related tyrosine kinase 4 | 0.107 | ||
TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.106 | ||
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.106 | ||
GGT5 | gamma-glutamyltransferase 5 | 0.105 | ||
CTSB | cathepsin B | 0.105 | ||
SP1 | Sp1 transcription factor | 0.105 | ||
FZD1 | frizzled homolog 1 (Drosophila) | 0.105 | ||
EPHA3 | EPH receptor A3 | 0.103 | Human | |
SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.103 | ||
PRKG1 | protein kinase, cGMP-dependent, type I | 0.103 | ||
EPHB2 | EPH receptor B2 | 0.103 | Human | |
NOTCH2 | notch 2 | 0.103 | Human | |
FGG | fibrinogen gamma chain | 0.103 | ||
KRT5 | keratin 5 | 0.102 | ||
HR | hairless homolog (mouse) | 0.102 | ||
TWIST1 | twist homolog 1 (Drosophila) | 0.102 | ||
RUNX1 | runt-related transcription factor 1 | 0.102 | ||
SOX18 | SRY (sex determining region Y)-box 18 | 0.101 | ||
BMP4 | bone morphogenetic protein 4 | 0.101 | ||
ITGB4 | integrin, beta 4 | 0.101 | Fly | |
WNT1 | wingless-type MMTV integration site family, member 1 | 0.100 | Human | |
GAS1 | growth arrest-specific 1 | 0.100 | ||
NID1 | nidogen 1 | 0.100 | ||
IGFBP5 | insulin-like growth factor binding protein 5 | 0.100 | ||
OAF | OAF homolog (Drosophila) | 0.100 | ||
EMP1 | epithelial membrane protein 1 | 0.099 | ||
GRB7 | growth factor receptor-bound protein 7 | 0.098 | ||
PDLIM1 | PDZ and LIM domain 1 | 0.098 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.098 | Human | |
KRT31 | keratin 31 | 0.098 | Human | |
FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.098 | ||
WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.098 | ||
CLDN5 | claudin 5 | 0.097 | ||
CALD1 | caldesmon 1 | 0.097 | ||
TRIM29 | tripartite motif containing 29 | 0.097 | ||
INHBB | inhibin, beta B | 0.097 | ||
RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.096 | ||
SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A | 0.096 | Rat | |
UNC119 | unc-119 homolog (C. elegans) | 0.095 | ||
CCL3 | chemokine (C-C motif) ligand 3 | 0.095 | Human | |
HOXA4 | homeobox A4 | 0.094 | Human | |
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.094 | ||
KRT16 | keratin 16 | 0.093 | ||
TRIM63 | tripartite motif containing 63 | 0.093 | ||
HEG1 | HEG homolog 1 (zebrafish) | 0.093 | ||
SFRP1 | secreted frizzled-related protein 1 | 0.093 | ||
TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.093 | ||
LAMB1 | laminin, beta 1 | 0.093 | ||
KRT14 | keratin 14 | 0.093 | Human | |
PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.093 | ||
NOS3 | nitric oxide synthase 3 (endothelial cell) | 0.092 | ||
MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.092 | ||
FZD7 | frizzled homolog 7 (Drosophila) | 0.092 | ||
ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.092 | ||
PCDH17 | protocadherin 17 | 0.092 | ||
KLF6 | Kruppel-like factor 6 | 0.092 | Human | |
PARVA | parvin, alpha | 0.091 | ||
DUSP5 | dual specificity phosphatase 5 | 0.091 | ||
NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.091 | ||
TBX1 | T-box 1 | 0.091 | Human | |
CCL7 | chemokine (C-C motif) ligand 7 | 0.091 | Human | |
ACAN | aggrecan | 0.090 | Rat | |
NGFR | nerve growth factor receptor | 0.090 | ||
FBLN2 | fibulin 2 | 0.090 | ||
ACTA2 | actin, alpha 2, smooth muscle, aorta | 0.090 | ||
FGF10 | fibroblast growth factor 10 | 0.090 | Human | |
ADARB1 | adenosine deaminase, RNA-specific, B1 | 0.090 | ||
SFRP4 | secreted frizzled-related protein 4 | 0.089 | ||
COL17A1 | collagen, type XVII, alpha 1 | 0.089 | ||
LAMA5 | laminin, alpha 5 | 0.089 | ||
EMILIN1 | elastin microfibril interfacer 1 | 0.089 | ||
DMD | dystrophin | 0.088 | ||
YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.088 | ||
PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.088 | ||
GAS6 | growth arrest-specific 6 | 0.088 | ||
WNT10A | wingless-type MMTV integration site family, member 10A | 0.088 | Human | |
WISP2 | WNT1 inducible signaling pathway protein 2 | 0.087 | ||
SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.087 | ||
RB1 | retinoblastoma 1 | 0.087 | ||
RASAL2 | RAS protein activator like 2 | 0.087 | Human | |
DLG1 | discs, large homolog 1 (Drosophila) | 0.087 | ||
HOXB9 | homeobox B9 | 0.087 | ||
CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.086 | ||
HTRA1 | HtrA serine peptidase 1 | 0.086 | ||
FHL2 | four and a half LIM domains 2 | 0.086 | ||
RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 0.086 | ||
SDC1 | syndecan 1 | 0.086 | ||
ZNF746 | zinc finger protein 746 | 0.084 | ||
HDAC4 | histone deacetylase 4 | 0.084 | Human | |
FGB | fibrinogen beta chain | 0.084 | Human | |
FGFR3 | fibroblast growth factor receptor 3 | 0.084 | ||
RNF20 | ring finger protein 20 | 0.084 | ||
ALK | anaplastic lymphoma receptor tyrosine kinase | 0.084 | ||
TRIP6 | thyroid hormone receptor interactor 6 | 0.084 | ||
BST2 | bone marrow stromal cell antigen 2 | 0.084 | ||
KIAA1199 | KIAA1199 | 0.083 | ||
PHLDB1 | pleckstrin homology-like domain, family B, member 1 | 0.083 | ||
DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.083 | ||
MADCAM1 | mucosal vascular addressin cell adhesion molecule 1 | 0.083 | ||
CD151 | CD151 molecule (Raph blood group) | 0.082 | ||
HOXC6 | homeobox C6 | 0.082 | Human | |
SMAD2 | SMAD family member 2 | 0.082 | ||
TNC | tenascin C | 0.082 | ||
RIN1 | Ras and Rab interactor 1 | 0.081 | ||
BMP7 | bone morphogenetic protein 7 | 0.080 | Human | |
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.080 | ||
STRN3 | striatin, calmodulin binding protein 3 | 0.080 | ||
LCAT | lecithin-cholesterol acyltransferase | 0.080 | ||
IHH | Indian hedgehog | 0.080 | ||
SKIL | SKI-like oncogene | 0.080 | ||
SH3PXD2A | SH3 and PX domains 2A | 0.080 | ||
CTGF | connective tissue growth factor | 0.080 | ||
MSC | musculin | 0.079 | ||
CARHSP1 | calcium regulated heat stable protein 1, 24kDa | 0.079 | ||
UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 0.079 | ||
CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.079 | ||
BCL2L1 | BCL2-like 1 | 0.078 | ||
GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.078 | ||
ALX3 | ALX homeobox 3 | 0.078 | ||
PLVAP | plasmalemma vesicle associated protein | 0.078 | ||
IRX4 | iroquois homeobox 4 | 0.078 | ||
PTHLH | parathyroid hormone-like hormone | 0.078 | ||
FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.078 | ||
NKG7 | natural killer cell group 7 sequence | 0.078 | ||
MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.077 | ||
RUNX2 | runt-related transcription factor 2 | 0.077 | ||
HSPG2 | heparan sulfate proteoglycan 2 | 0.077 | ||
COL18A1 | collagen, type XVIII, alpha 1 | 0.077 | ||
KRT1 | keratin 1 | 0.077 | ||
MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.077 | ||
CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.077 | ||
DLL4 | delta-like 4 (Drosophila) | 0.077 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.077 | ||
CLEC4G | C-type lectin domain family 4, member G | 0.076 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.076 | ||
HYAL2 | hyaluronoglucosaminidase 2 | 0.076 | ||
CALCA | calcitonin-related polypeptide alpha | 0.076 | ||
MMP19 | matrix metallopeptidase 19 | 0.076 | ||
IGFBP6 | insulin-like growth factor binding protein 6 | 0.076 | Human | |
APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.076 | ||
WISP1 | WNT1 inducible signaling pathway protein 1 | 0.075 | ||
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.075 | Rat | |
NOG | noggin | 0.075 | ||
CPE | carboxypeptidase E | 0.075 | ||
APOA1 | apolipoprotein A-I | 0.075 | Human | |
CCL21 | chemokine (C-C motif) ligand 21 | 0.074 | ||
JUN | jun proto-oncogene | 0.074 | ||
C10orf10 | chromosome 10 open reading frame 10 | 0.074 | ||
CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.074 | ||
TRIO | triple functional domain (PTPRF interacting) | 0.074 | ||
SASH3 | SAM and SH3 domain containing 3 | 0.073 | ||
ACTN4 | actinin, alpha 4 | 0.073 | Human Mouse | |
FNDC3B | fibronectin type III domain containing 3B | 0.073 | ||
NEUROG2 | neurogenin 2 | 0.073 | ||
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.073 | ||
MUC1 | mucin 1, cell surface associated | 0.072 | ||
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.072 | ||
KRT35 | keratin 35 | 0.072 | Human | |
ADAM12 | ADAM metallopeptidase domain 12 | 0.072 | Human | |
MYOF | myoferlin | 0.072 | ||
FAF1 | Fas (TNFRSF6) associated factor 1 | 0.072 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.072 | ||
UNC5B | unc-5 homolog B (C. elegans) | 0.072 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.071 | Human | |
LAMB3 | laminin, beta 3 | 0.071 | ||
ANGPT1 | angiopoietin 1 | 0.071 | Human | |
CD9 | CD9 molecule | 0.071 | ||
CLDN1 | claudin 1 | 0.071 | ||
LTBP2 | latent transforming growth factor beta binding protein 2 | 0.070 | ||
PLXDC1 | plexin domain containing 1 | 0.070 | ||
SH3D19 | SH3 domain containing 19 | 0.070 | ||
PLXND1 | plexin D1 | 0.070 | Human | |
TFAP2B | transcription factor AP-2 beta (activating enhancer binding protein 2 beta) | 0.070 | ||
FOXD3 | forkhead box D3 | 0.070 | ||
ITGB7 | integrin, beta 7 | 0.070 | Fly | |
TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.069 | ||
VSIG4 | V-set and immunoglobulin domain containing 4 | 0.068 | ||
PRDM8 | PR domain containing 8 | 0.068 | ||
ARRB1 | arrestin, beta 1 | 0.067 | ||
HOXA11 | homeobox A11 | 0.067 | ||
RAI14 | retinoic acid induced 14 | 0.067 | ||
PSEN1 | presenilin 1 | 0.067 | ||
KIF1B | kinesin family member 1B | 0.067 | ||
ANGPTL4 | angiopoietin-like 4 | 0.067 | ||
PTPRD | protein tyrosine phosphatase, receptor type, D | 0.067 | Human | |
SAMD4A | sterile alpha motif domain containing 4A | 0.066 | ||
APLNR | apelin receptor | 0.066 | ||
WASF1 | WAS protein family, member 1 | 0.066 | ||
NOTCH2NL | notch 2 N-terminal like | 0.066 | ||
ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.066 | ||
PYY | peptide YY | 0.066 | ||
HOXB7 | homeobox B7 | 0.066 | Human | |
ESR1 | estrogen receptor 1 | 0.066 | ||
PDGFC | platelet derived growth factor C | 0.066 | ||
HMOX2 | heme oxygenase (decycling) 2 | 0.066 | ||
ALB | albumin | 0.066 | ||
EHMT2 | euchromatic histone-lysine N-methyltransferase 2 | 0.066 | ||
CFH | complement factor H | 0.066 | ||
HCK | hemopoietic cell kinase | 0.065 | ||
MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.065 | ||
BBS10 | Bardet-Biedl syndrome 10 | 0.065 | ||
ARL4C | ADP-ribosylation factor-like 4C | 0.065 | ||
CARD10 | caspase recruitment domain family, member 10 | 0.065 | ||
ACVRL1 | activin A receptor type II-like 1 | 0.065 | ||
KRT33A | keratin 33A | 0.064 | Human | |
ITIH5 | inter-alpha (globulin) inhibitor H5 | 0.064 | ||
IL10 | interleukin 10 | 0.063 | ||
HDAC1 | histone deacetylase 1 | 0.063 | ||
NFIB | nuclear factor I/B | 0.063 | ||
PTGES | prostaglandin E synthase | 0.063 | ||
MST1R | macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | 0.063 | ||
EPHX3 | epoxide hydrolase 3 | 0.063 | ||
SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.063 | ||
COL6A3 | collagen, type VI, alpha 3 | 0.063 | ||
KSR1 | kinase suppressor of ras 1 | 0.063 | ||
HOXA3 | homeobox A3 | 0.063 | ||
PGR | progesterone receptor | 0.062 | ||
DTNA | dystrobrevin, alpha | 0.062 | ||
MYO1C | myosin IC | 0.062 | ||
TRAF3IP3 | TRAF3 interacting protein 3 | 0.062 | ||
C2 | complement component 2 | 0.062 | ||
IL13 | interleukin 13 | 0.061 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.061 | ||
SCRT1 | scratch homolog 1, zinc finger protein (Drosophila) | 0.061 | ||
HOXC5 | homeobox C5 | 0.061 | Human | |
LRP1 | low density lipoprotein receptor-related protein 1 | 0.061 | Mouse | |
MX1 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | 0.061 | ||
TFAP2C | transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | 0.061 | ||
GFI1B | growth factor independent 1B transcription repressor | 0.061 | ||
RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.061 | ||
HES1 | hairy and enhancer of split 1, (Drosophila) | 0.061 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.060 | ||
MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.060 | ||
RND3 | Rho family GTPase 3 | 0.060 | ||
MYOZ1 | myozenin 1 | 0.060 | ||
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.060 | ||
SP110 | SP110 nuclear body protein | 0.060 | Human | |
GJA4 | gap junction protein, alpha 4, 37kDa | 0.060 | ||
EDN1 | endothelin 1 | 0.060 | ||
KRT38 | keratin 38 | 0.060 | Human | |
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.060 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.060 | ||
TSG101 | tumor susceptibility gene 101 | 0.059 | ||
FGF6 | fibroblast growth factor 6 | 0.059 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.059 | ||
SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.059 | ||
IL8 | interleukin 8 | 0.059 | ||
CHIT1 | chitinase 1 (chitotriosidase) | 0.059 | ||
TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.059 | ||
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.059 | ||
TPM4 | tropomyosin 4 | 0.059 | ||
CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 0.059 | ||
CRMP1 | collapsin response mediator protein 1 | 0.058 | ||
CCND3 | cyclin D3 | 0.058 | ||
HOXC8 | homeobox C8 | 0.058 | Human | |
FSTL1 | follistatin-like 1 | 0.058 | ||
PCDH9 | protocadherin 9 | 0.058 | ||
ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | 0.058 | ||
CDX1 | caudal type homeobox 1 | 0.058 | ||
SMAD7 | SMAD family member 7 | 0.058 | ||
CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0.058 | ||
SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.057 | ||
IL2RG | interleukin 2 receptor, gamma | 0.057 | ||
CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.057 | ||
IFI44L | interferon-induced protein 44-like | 0.057 | ||
GPC3 | glypican 3 | 0.057 | ||
DISC1 | disrupted in schizophrenia 1 | 0.057 | ||
CALCR | calcitonin receptor | 0.057 | ||
FZD8 | frizzled homolog 8 (Drosophila) | 0.057 | ||
PLXNB2 | plexin B2 | 0.057 | Human | |
DLC1 | deleted in liver cancer 1 | 0.057 | ||
SOCS3 | suppressor of cytokine signaling 3 | 0.057 | ||
IL2RB | interleukin 2 receptor, beta | 0.056 | ||
APOC3 | apolipoprotein C-III | 0.056 | ||
WNT6 | wingless-type MMTV integration site family, member 6 | 0.056 | Human | |
KRT32 | keratin 32 | 0.056 | Human | |
HOXC4 | homeobox C4 | 0.056 | Human | |
LOXL2 | lysyl oxidase-like 2 | 0.056 | ||
GATA5 | GATA binding protein 5 | 0.056 | Human | |
C1S | complement component 1, s subcomponent | 0.056 | ||
STC1 | stanniocalcin 1 | 0.055 | ||
FGFBP1 | fibroblast growth factor binding protein 1 | 0.055 | ||
MED31 | mediator complex subunit 31 | 0.055 | ||
TCF21 | transcription factor 21 | 0.055 | ||
EGFR | epidermal growth factor receptor | 0.055 | ||
CLSTN1 | calsyntenin 1 | 0.055 | ||
ARHGEF40 | Rho guanine nucleotide exchange factor (GEF) 40 | 0.055 | ||
VTN | vitronectin | 0.055 | ||
STK24 | serine/threonine kinase 24 | 0.054 | ||
PCDH12 | protocadherin 12 | 0.054 | ||
NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.054 | ||
TPBG | trophoblast glycoprotein | 0.054 | ||
TG | thyroglobulin | 0.054 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.054 | ||
KCNMA1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | 0.054 | ||
PTOV1 | prostate tumor overexpressed 1 | 0.053 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.053 | ||
MXRA8 | matrix-remodelling associated 8 | 0.053 | ||
CD81 | CD81 molecule | 0.053 | ||
ADAM19 | ADAM metallopeptidase domain 19 | 0.053 | Human | |
HOXD9 | homeobox D9 | 0.053 | ||
ISLR | immunoglobulin superfamily containing leucine-rich repeat | 0.053 | ||
DSCAML1 | Down syndrome cell adhesion molecule like 1 | 0.052 | ||
TES | testis derived transcript (3 LIM domains) | 0.052 | ||
TNXB | tenascin XB | 0.052 | ||
FOXC1 | forkhead box C1 | 0.052 | ||
BHLHE23 | basic helix-loop-helix family, member e23 | 0.052 | ||
MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 0.052 | ||
KRT37 | keratin 37 | 0.051 | Human | |
NKX6-1 | NK6 homeobox 1 | 0.051 | ||
LPAR1 | lysophosphatidic acid receptor 1 | 0.051 | ||
FOXF2 | forkhead box F2 | 0.051 | ||
CH25H | cholesterol 25-hydroxylase | 0.051 | ||
CCDC85B | coiled-coil domain containing 85B | 0.051 | ||
TLX1 | T-cell leukemia homeobox 1 | 0.051 | ||
SH2D2A | SH2 domain containing 2A | 0.051 | ||
AHNAK | AHNAK nucleoprotein | 0.050 | ||
NOV | nephroblastoma overexpressed gene | 0.050 | ||
MECOM | MDS1 and EVI1 complex locus | 0.050 | ||
SIM2 | single-minded homolog 2 (Drosophila) | 0.050 | ||
NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.050 | ||
PPARA | peroxisome proliferator-activated receptor alpha | 0.050 | ||
FST | follistatin | 0.050 | ||
RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.050 | ||
ADAMTS7 | ADAM metallopeptidase with thrombospondin type 1 motif, 7 | 0.050 | ||
EPHB4 | EPH receptor B4 | 0.050 | Human | |
MRC2 | mannose receptor, C type 2 | 0.050 | ||
ADRB2 | adrenergic, beta-2-, receptor, surface | 0.050 | ||
DHH | desert hedgehog | 0.049 | ||
ANXA5 | annexin A5 | 0.049 | ||
CLDN4 | claudin 4 | 0.049 | ||
DOK2 | docking protein 2, 56kDa | 0.049 | ||
KRT2 | keratin 2 | 0.049 | ||
IFNG | interferon, gamma | 0.049 | ||
NAMPT | nicotinamide phosphoribosyltransferase | 0.049 | ||
SPRR1A | small proline-rich protein 1A | 0.049 | ||
SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 | 0.049 | ||
FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.049 | ||
PRRX1 | paired related homeobox 1 | 0.049 | ||
ACVR2B | activin A receptor, type IIB | 0.049 | ||
LAMC2 | laminin, gamma 2 | 0.049 | ||
GJA1 | gap junction protein, alpha 1, 43kDa | 0.049 | ||
FOXA2 | forkhead box A2 | 0.049 | ||
EPAS1 | endothelial PAS domain protein 1 | 0.049 | ||
GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.049 | ||
RHOB | ras homolog gene family, member B | 0.049 | ||
NOS1 | nitric oxide synthase 1 (neuronal) | 0.048 | ||
TREM2 | triggering receptor expressed on myeloid cells 2 | 0.048 | ||
PALLD | palladin, cytoskeletal associated protein | 0.048 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.048 | ||
CLEC4M | C-type lectin domain family 4, member M | 0.048 | ||
IDE | insulin-degrading enzyme | 0.048 | ||
NNMT | nicotinamide N-methyltransferase | 0.048 | ||
MARCO | macrophage receptor with collagenous structure | 0.048 | ||
FGF7 | fibroblast growth factor 7 | 0.048 | Human | |
ARHGEF15 | Rho guanine nucleotide exchange factor (GEF) 15 | 0.048 | ||
TIAM1 | T-cell lymphoma invasion and metastasis 1 | 0.048 | ||
CIITA | class II, major histocompatibility complex, transactivator | 0.048 | ||
FAM40B | family with sequence similarity 40, member B | 0.048 | ||
SFRP5 | secreted frizzled-related protein 5 | 0.048 | Human | |
TGFBI | transforming growth factor, beta-induced, 68kDa | 0.048 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.048 | ||
LY6E | lymphocyte antigen 6 complex, locus E | 0.047 | ||
CELSR2 | cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila) | 0.047 | ||
SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 0.047 | ||
VAX2 | ventral anterior homeobox 2 | 0.047 | ||
SOX1 | SRY (sex determining region Y)-box 1 | 0.047 | ||
MBP | myelin basic protein | 0.047 | ||
FGF4 | fibroblast growth factor 4 | 0.047 | Human | |
PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | 0.047 | ||
DDAH2 | dimethylarginine dimethylaminohydrolase 2 | 0.047 | ||
SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.047 | ||
FZD10 | frizzled homolog 10 (Drosophila) | 0.047 | ||
CDX2 | caudal type homeobox 2 | 0.046 | ||
CSF1R | colony stimulating factor 1 receptor | 0.046 | ||
TBC1D10A | TBC1 domain family, member 10A | 0.046 | ||
MPRIP | myosin phosphatase Rho interacting protein | 0.046 | ||
NAV3 | neuron navigator 3 | 0.046 | ||
DDX21 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 | 0.046 | ||
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.046 | ||
SEMA7A | semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) | 0.046 | ||
FES | feline sarcoma oncogene | 0.046 | ||
CAV2 | caveolin 2 | 0.046 | ||
GSN | gelsolin | 0.045 | ||
CD59 | CD59 molecule, complement regulatory protein | 0.045 | ||
KCNK15 | potassium channel, subfamily K, member 15 | 0.045 | ||
PSORS1C2 | psoriasis susceptibility 1 candidate 2 | 0.045 | ||
SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.045 | ||
ASRGL1 | asparaginase like 1 | 0.045 | ||
PRRX2 | paired related homeobox 2 | 0.045 | ||
IL11 | interleukin 11 | 0.045 | ||
NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.045 | ||
UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.045 | ||
NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.045 | ||
HOXD3 | homeobox D3 | 0.045 | ||
EPHB6 | EPH receptor B6 | 0.045 | Human | |
STOM | stomatin | 0.045 | ||
LY6D | lymphocyte antigen 6 complex, locus D | 0.045 | ||
TBX21 | T-box 21 | 0.045 | Human | |
LPP | LIM domain containing preferred translocation partner in lipoma | 0.045 | ||
FEV | FEV (ETS oncogene family) | 0.044 | ||
SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 0.044 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.044 | ||
CCNE1 | cyclin E1 | 0.044 | ||
HOXA5 | homeobox A5 | 0.044 | Human | |
HOXD10 | homeobox D10 | 0.044 | ||
HOXC11 | homeobox C11 | 0.044 | ||
PRKCA | protein kinase C, alpha | 0.044 | ||
COL7A1 | collagen, type VII, alpha 1 | 0.044 | ||
ECEL1 | endothelin converting enzyme-like 1 | 0.044 | ||
INO80B | INO80 complex subunit B | 0.044 | ||
ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 0.044 | ||
SPP1 | secreted phosphoprotein 1 | 0.044 | ||
ANTXR2 | anthrax toxin receptor 2 | 0.044 | ||
PDCD6IP | programmed cell death 6 interacting protein | 0.044 | ||
SELPLG | selectin P ligand | 0.044 | ||
WNT11 | wingless-type MMTV integration site family, member 11 | 0.044 | ||
MYOCD | myocardin | 0.044 | ||
HAS2 | hyaluronan synthase 2 | 0.043 | Human | |
TACR1 | tachykinin receptor 1 | 0.043 | ||
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.043 | ||
TNMD | tenomodulin | 0.043 | ||
EDN2 | endothelin 2 | 0.043 | ||
SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.043 | ||
WNT4 | wingless-type MMTV integration site family, member 4 | 0.043 | Human | |
COL14A1 | collagen, type XIV, alpha 1 | 0.043 | ||
KLF2 | Kruppel-like factor 2 (lung) | 0.043 | Human | |
GDNF | glial cell derived neurotrophic factor | 0.043 | ||
HOXD11 | homeobox D11 | 0.043 | ||
FMNL1 | formin-like 1 | 0.043 | ||
MMP13 | matrix metallopeptidase 13 (collagenase 3) | 0.042 | ||
CCL20 | chemokine (C-C motif) ligand 20 | 0.042 | Human | |
DDX24 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 | 0.042 | ||
HMGA2 | high mobility group AT-hook 2 | 0.042 | ||
RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 0.042 | ||
CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.042 | Human | |
PRR13 | proline rich 13 | 0.042 | ||
HAND2 | heart and neural crest derivatives expressed 2 | 0.042 | ||
PFN2 | profilin 2 | 0.042 | ||
SCARF1 | scavenger receptor class F, member 1 | 0.042 | ||
YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.042 | ||
POU3F4 | POU class 3 homeobox 4 | 0.042 | ||
HOXD1 | homeobox D1 | 0.042 | ||
TNFRSF4 | tumor necrosis factor receptor superfamily, member 4 | 0.042 | ||
AQP5 | aquaporin 5 | 0.042 | ||
THRB | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) | 0.042 | ||
ARRDC3 | arrestin domain containing 3 | 0.042 | ||
PIN1 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.042 | ||
DIO3 | deiodinase, iodothyronine, type III | 0.042 | ||
HLX | H2.0-like homeobox | 0.042 | ||
HOXA7 | homeobox A7 | 0.042 | ||
MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.041 | ||
MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.041 | ||
SHH | sonic hedgehog | 0.041 | ||
TBX3 | T-box 3 | 0.041 | Human | |
CA9 | carbonic anhydrase IX | 0.041 | ||
SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.041 | ||
IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.041 | Human | |
HOXD8 | homeobox D8 | 0.041 | Human | |
ADRA2B | adrenergic, alpha-2B-, receptor | 0.041 | ||
HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.041 | ||
PDE10A | phosphodiesterase 10A | 0.041 | ||
NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 0.041 | ||
C5AR1 | complement component 5a receptor 1 | 0.041 | ||
BCL6B | B-cell CLL/lymphoma 6, member B | 0.041 | ||
KIAA1217 | KIAA1217 | 0.041 | ||
PLXNA2 | plexin A2 | 0.041 | Human | |
TP73 | tumor protein p73 | 0.041 | ||
HMX1 | H6 family homeobox 1 | 0.041 | ||
HTRA3 | HtrA serine peptidase 3 | 0.041 | ||
SCARB2 | scavenger receptor class B, member 2 | 0.041 | ||
PPFIBP1 | PTPRF interacting protein, binding protein 1 (liprin beta 1) | 0.041 | ||
TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.041 | ||
BTBD2 | BTB (POZ) domain containing 2 | 0.040 | ||
PHLDA2 | pleckstrin homology-like domain, family A, member 2 | 0.040 | ||
PPP2R2B | protein phosphatase 2, regulatory subunit B, beta | 0.040 | ||
LEP | leptin | 0.040 | ||
PAX3 | paired box 3 | 0.040 | ||
PALM | paralemmin | 0.040 | ||
MEGF11 | multiple EGF-like-domains 11 | 0.040 | ||
SREBF2 | sterol regulatory element binding transcription factor 2 | 0.040 | ||
C1QTNF1 | C1q and tumor necrosis factor related protein 1 | 0.040 | Human | |
PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 0.040 | ||
PAX9 | paired box 9 | 0.040 | ||
GJB3 | gap junction protein, beta 3, 31kDa | 0.040 |